ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
FDA Patent Settlement legislation Intellectual property and patent issues S. 340, H.R. 965 CREATES Act S. 1209, REMEDY Act S. 1224, H.R. 2374, Stop STALLING Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Health Issues HCR
Value of Prescription Drugs Drug Pricing Transparency Oncology Care Model Personalized Medicine Diagnostics S. 1895, Lower Health Care Costs Act HR 3 Drug pricing bill Rebate Reform USMCA
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Medicare/Medicaid MMM
Medicare Part D Coverage and Reimbursement Medicare Part D Non-Interference Legislative proposals to change Medicare Part D Medicare Part B coverage and reimbursement Changes to the Medicaid Drug Rebate Program (AMP Cap) Medicare Part B Intl. Pricing Index ANPRM -14 Day Rule End State Renal Disease PPS H.R. 107, To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs Final Rule: Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | . |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Pharmacy PHA
Medicare Part D coverage and reimbursement Value of Prescription Drugs, Senate & House Prescription Drug Importation, Senate & House Innovative Payment Models, Senate & House, CMS Price Transparency, Senate & House Legislative proposals to change Medicare Part D Medicaid and 340B issues & drug discount program International Pricing Index Model (IPI) H.R. 1499, Protecting Consumer Access to Generic Drugs Act S. 1416, Affordable prescriptions for Patients Act S. 64, H.R. 2375, Preserve Access to Affordable Generics and Biosimilars Act NPRM: Importation of Prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| MORGAN BRADLEY-JONES | — |
| HELEN DWIGHT | — |
| JULIE GARNER | — |
| NATALIE MORRIS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.